Research Articles | Page 67 | Aplastic Anemia and MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Titlesort descending Original Publication Date Journal Bone Marrow Disease
Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study Jan 2013 Leukemia myelodysplastic syndromes (MDS)
Serial assessment of suspected myelodysplastic syndromes: significance of flow cytometric findings validated by cytomorphology, cytogenetics, and molecular genetics Aug 2012 Haematologica myelodysplastic syndromes (MDS)
Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab Jan 2017 Ann Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium study. Mar 2012 Leuk Res paroxysmal nocturnal hemoglobinuria (PNH)
SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias Feb 2013 Leukemia myelodysplastic syndromes (MDS)
SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes Jul 2012 Blood myelodysplastic syndromes (MDS)
SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution Apr 2014 Am J Hematol myelodysplastic syndromes (MDS)
Shelf-life Extension of Azacitidine: Waste and Cost Reduction in the Treatment of Myelodysplastic Syndromes May 2014 Leuk Lymphoma myelodysplastic syndromes (MDS)
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy. Jun 2013 Transl Res aplastic anemia
Short- and long-term benefits of lenalidomide treatment in patients with lower-risk del(5q) myelodysplastic syndromes Oct 2015 Ann Oncol myelodysplastic syndromes (MDS)